SecBot SecBot

MCHX

MARCHEX INC
Nasdaq· Services-Prepackaged Software· Inc. DE· CIK 0001224133 Software & IT
$1.37 +0.11 (+8.83%)
Oct 27 4:00 PM ET · prev $1.26
Market cap
$57.2M
Micro cap
Median target
$4.00
+192% · range $4.00–4.00
Next earnings
Nov 11
in 15 days · EPS est. $0.04
1 year
−24.7%
from $1.82 · Oct 27
30 days
+3.9%
from $1.32
52-week range
$1.22–1.90
−28% from high · low Oct 15
Avg volume 20D
30.8K
shares / day
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 11, 2026
Strongest MIXED Marchex reported Q2 2026 GAAP revenue of $11.0M (down 5.6% YoY from $11.7M) and a GAAP net loss of $0.4M…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q1 2026: 1 added (0 new), 0 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate $0.030 → $0.040 over 90 days. 1 up, 0 down in 30 days.

  • TrendDOWNTREND

    5% below its 50-day average.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED626$970.00
UBS Group AGADD85$141.00
BANK OF AMERICA CORP /DE/NEAR_EXIT38$69.00
BNP PARIBAS FINANCIAL MARKETSNEAR_EXIT2$4.00
JPMORGAN CHASE & COTRIM43$93.00
SIMPLEX TRADING, LLCNEAR_EXIT2—
UBS Group AGDOUBLED5,909$9.6K
GOLDMAN SACHS GROUP INCTRIM49,763$87.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Dec 2021
12-month targets · 1 analysts

Price is below the lowest target. Median implies +192%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Dec 28, 2021Roth Capital
MAINTAIN
MAINTAINBuy
Jan 28, 2019Roth Capital
UPGRADE
UPGRADEBuy
Aug 10, 2016Roth Capital
DOWNGRADE
DOWNGRADENeutral
Dec 21, 2015Roth Capital
INITIATE
INITIATEBuy
Jun 30, 2015HC Wainwright & Co.
DOWNGRADE
DOWNGRADEEqual-Weight
Sep 19, 2014BMO Capital
DOWNGRADE
DOWNGRADEMarket Perform

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 1, 2026
ARENDS MICHAEL A
Vice Chairman
AWARD$17.2T
Jul 1, 2026
HOROWITZ RUSSELL C
Chairman
AWARD$23.7T
Mar 20, 2026
HARTLESS TROY
President & Chief Rev Officer
EXERCISE87,500 sh
Mar 20, 2026
Feeney Francis J
Chief Operating Officer & CLO
EXERCISE62,500 sh
Mar 20, 2026
Nagle Brian
Chief Financial Officer
EXERCISE7,500 sh

Earnings setup

Estimates
Nov 11
reports in 15 days
$0.04
EPS estimate, this quarter
+33%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.04$0.04–$0.04+33.3%$16.2M
Next Q$0.03$0.03–$0.03+50.0%$15.6M
Current FY$0.04$0.04–$0.04-20.0%$53.5M
Next FY$0.16$0.16–$0.16—$69.4M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 27, 2026 Press
🔒 Fresh report (last 24h), subscribers only
Oct 27, 2026 Contract
🔒 Fresh data, subscribers only
Sep 22, 2026 Press
Marchex has engaged PondelWilkinson, an investor relations firm, to support an expanded IR program aimed at increasing…
Impact 2/10
Aug 12, 2026 SEC
Marchex reported Q2 2026 GAAP revenue of $11.0M (down 5.6% YoY from $11.7M) and a GAAP net loss of $0.4M…
8-K — Impact 6/10
Jul 1, 2026 Insider
ARENDS MICHAEL A was granted 4,144,144 shares
Vice Chairman @ $4,144,144.00 ($17.2T)
Jul 1, 2026 Insider
HOROWITZ RUSSELL C was granted 4,864,865 shares
Chairman @ $4,864,865.00 ($23.7T)
Jun 5, 2026 SEC
Marchex is seeking stockholder approval to acquire Archenia, a performance-based marketing tech company, from insiders…
DEFM14A — Impact 5/10
May 26, 2026 SEC
Marchex is seeking stockholder approval for a related-party acquisition of Archenia, Inc., from its Chairman (Russell…
PREM14A — Impact 5/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
MCHX Q3 2026 Earnings Scheduled — 2026-11-11
Recent
Oct 27, 2026
Contract
🔒 Fresh data, subscribers only
Sep 22, 2026
M&A
Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach
Initiative follows Archenia acquisition and Marchex’s evolution into a comprehensive AI-driven customer acquisition and outcome optimization…
Sep 16, 2026
Press release
Marchex Expands Existing Customer Relationship with Commercial Deployment of AI Voice Agent
Successful Paid Pilot Conversion Further Highlights Cross-Sell Opportunity Across Marchex’s Current Customer Base Successful Paid Pilot Conversion…
Aug 12, 2026
Earnings
Marchex Announces Second Quarter 2026 Financial Results
Reports Improved Profitability and Early Momentum Following Archenia Acquisition Reports Improved Profitability and Early Momentum Following…
Aug 12, 2026
Earnings date
MCHX Q2 2026 Earnings Scheduled — 2026-08-12

SecBot reports

7 filings · 2 press releases · 0 bullish · 0 bearish · 4 mixed · 3 neutral
All MCHX filing & press-release reports (9)